Tezosentan in the Treatment of Acute Heart Failure

Clinical trial NCT00524433 · COMPLETED

Trial details

NCT number: NCT00524433
Sponsor: Idorsia Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Heart Failure Acute Decompensation of Chronic Heart Failure New Onset of Heart Failure

Start date: 2003-04-01
Primary completion: 2005-01-01
Enrollment: 713

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.